Australia-based cannabis grower and producer Little Green Pharma (ASX: LPG) reported its financial results for the quarter ended Sep 30, revealing unaudited record revenue of AU$10.2 million ($6.85 million). This marks a 40% increase from the prior quarter and nearly 60% from the corresponding quarter last year. By product category, the company saw a 45% increase in oil sales, driven by growth in both France and Australia, and over a 35% increase in flower sales, driven by both the company’s brands and white-label sales. At the same time, vaporizer sales declined 20%. Quarterly Financial Highl…
